Nicardipine Drip Titration Protocol
Initial Dosing and Titration Intervals
Start nicardipine at 5 mg/hr IV infusion and increase by 2.5 mg/hr every 5-15 minutes until desired blood pressure reduction is achieved, with a maximum dose of 15 mg/hr. 1, 2, 3, 4
Titration Speed Based on Clinical Urgency
- For gradual blood pressure reduction: Increase by 2.5 mg/hr every 15 minutes 3
- For more rapid blood pressure reduction: Increase by 2.5 mg/hr every 5 minutes 1, 3, 4
- The FDA-approved dosing allows for adjustments every 5 minutes when rapid control is needed, though 15-minute intervals are preferred for most situations to avoid precipitous drops 4
Blood Pressure Monitoring Requirements
During Active Titration
After Achieving Target Blood Pressure
- Monitor every 15 minutes for the first 2 hours after reaching target 1, 2
- Then every 30 minutes for the next 6 hours 1, 2
- Then hourly for 16 hours 1, 2
Once Stable on Maintenance Dose
- Extend monitoring intervals to every 30 minutes once a stable maintenance rate is achieved 1
Target Blood Pressure Goals by Clinical Scenario
Thrombolytic-Eligible Stroke Patients
- Strict target: <185/110 mmHg before and during rtPA administration 1, 3
- Do not administer rtPA if blood pressure cannot be maintained below this threshold at maximum nicardipine dose 2
Post-Thrombolytic Stroke Patients
General Severe Hypertension (Non-Stroke)
- Target: 10-15% reduction from baseline, not normalization 5, 1, 3
- Avoid exceeding 25% reduction in the first 24 hours to prevent organ hypoperfusion 5, 2
Maintenance Dosing After Achieving Target
- Reduce to 3 mg/hr as a maintenance dose once desired blood pressure is attained 2
- The average maintenance dose in clinical trials was 8.0 mg/hr for severe hypertension and 3 mg/hr for postoperative hypertension 4
- Sustained blood pressure control is maintained at a constant infusion rate for 4-6 hours 2
When to Stop or Reduce the Infusion
If Hypotension or Tachycardia Develops
- Immediately discontinue the infusion 4
- After blood pressure stabilizes, restart at a lower dose such as 3-5 mg/hr 4
Downtitration Protocol for Normalized Blood Pressure
- Decrease by 2.5 mg/hr every 5-15 minutes while continuously monitoring blood pressure 2
- Find the lowest effective maintenance rate that keeps blood pressure at target 2
- Monitor blood pressure every 15 minutes during downtitration, then extend to every 30 minutes for 6 hours once stable 2
Critical Safety Considerations
Avoid Excessive Blood Pressure Reduction
- In patients with chronic severe hypertension, autoregulation of tissue perfusion is disturbed, making precipitous drops dangerous 2
- In acute stroke patients, exercise extreme caution to avoid systemic hypotension, as cerebral autoregulation is impaired 3
- In ischemic stroke, blood pressure reduction within the first 5-7 days is associated with adverse neurological outcomes 2
Infusion Site Management
- Change the infusion site every 12 hours to minimize peripheral venous irritation and phlebitis 4
- Avoid small veins such as those on the dorsum of the hand or wrist 4
- Local phlebitis typically occurs after at least 14 hours of infusion at a single site 6
When Maximum Dose Fails
- If blood pressure remains uncontrolled at 15 mg/hr nicardipine (the absolute maximum), consider switching to sodium nitroprusside 1
- Alternative: Labetalol 10-20 mg IV bolus over 1-2 minutes, which may be repeated every 10-20 minutes up to 300 mg maximum 1, 2
Pharmacokinetic Considerations
- Onset of action: 5-15 minutes 2, 4
- Offset of action: 30-40 minutes after discontinuation, regardless of infusion duration 2, 6
- Higher infusion rates (15 mg/hr) produce therapeutic responses more rapidly (mean 18 minutes) compared to lower doses (4 mg/hr: mean 66 minutes) 6
Common Pitfalls to Avoid
- Do not titrate too aggressively in stroke patients—maintain blood pressure at the higher end of acceptable ranges during downtitration 2
- Do not assume the patient needs the same blood pressure target as during the acute phase—reassess based on current clinical status 2
- Do not use nicardipine as a substitute for beta-blocker withdrawal protection—it provides no protection against abrupt beta-blocker withdrawal 4